AMSilk GmbH’s €29 Million Series C Financing Round

honert + partner advised existing investor Athos KG on the deal.

The manufacturer of biopolymers made from artificial silk has successfully completed its Series C financing.

The volume of the Series C financing amounts to 29 million euros. In addition to the existing investors ATHOS KG and various MIG Funds, the new investors Novo Holdings, Cargill and E.R. Capital Holdings participated, whereby the fundraise was led by Novo Growth, a subsidiary of Novo Holdings.

AMSilk GmbH, based in Planegg, is the world’s first industrial manufacturer of vegan silk biopolymers and produces sustainable products from biomaterials and is one of the world’s leading manufacturers of innovative high-performance biotech materials.

ATHOS KG is a family office of a German entrepreneurial family, which, among other things, invests directly in companies with a long-term and entrepreneurial orientation.

The honert + partner mbB team was led by partner Sven Fritsche (Picture) and senior associate Dr. Kai-Klemens Wehlage.

Involved fees earner: Sven Fritsche – Honert + Partner; Kai-Klemens Wehlage – Honert + Partner;

Law Firms: Honert + Partner;

Clients: ATHOS KG;

Author: Federica Tiefenthaler